Publication | Open Access
Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series
24
Citations
36
References
2020
Year
Tocilizumab could be an adjunct safe therapy in rapidly evolving COVID-19 pneumonia and associated critical illness.
| Year | Citations | |
|---|---|---|
Page 1
Page 1